Joint Managing Director Of Bharat Biotech

Rediff.com » News » Joint Managing Director Of Bharat Biotech

News for Joint Managing Director Of Bharat Biotech

News
Business

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Bharat Biotech has recruited 23,000 volunteers and continued to progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple......

50 employees of Bharat Biotech test Covid positive

Bharat Biotech's Joint Managing Director Suchitra Ella's tweet saying 50 of their employees tested positive for COVID-19 received bouquets and brickbats from netizens, with some saying Covaxin was......

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Delhi govt vs Bharat Biotech over Covaxin supply

Deputy Chief Minister Manish Sisodia on Wednesday said Covaxin maker Bharat Biotech has refused to provide "additional" vaccine doses to the Delhi government, a development that is likely to......

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. ......

Four lessons of change from Tata Communications CEO

Unlike many of his peers in corporate houses, Kumar doesn't have an MBA but says that hardly matters, as he has been lucky to have got great on-the-job experience, such as during his stint in Asia......

Joint Managing Director Of Bharat Biotech

News for Joint Managing Director Of Bharat Biotech

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

50 employees of Bharat Biotech test Covid positive

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Delhi govt vs Bharat Biotech over Covaxin supply

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Four lessons of change from Tata Communications CEO

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS